National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 87384-87385 [2024-25418]

Download as PDF 87384 Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form # Form name 144 ................... Adult Heart and HeartLung Status 4 Exception Extension Justification Form Medical Urgency Data ***. Adult Heart and HeartLung Status 4 Criteria 2 Extension Justification Form Medical Urgency Data ***. Adult and Pediatric Lung and HeartLung Goal Exception Form *** Pediatric Lung Priority 1 Status Justification Form *** ..................... Review Board Voter Form *** ........................................................... Living Donor Feedback Form *** ...................................................... Extra Vessels Reporting Form *** .................................................... Non-US Transplants Reporting Form *** ......................................... Discrepant HLA Typings Reporting Form *** ................................... Interim Event Reporting Form *** ..................................................... Total .......................................................................................... 145 ................... 146 147 148 149 150 151 152 153 ................... ................... ................... ................... ................... ................... ................... ................... Number of responses per respondent **** Total responses Average burden per response (in hours) Total burden hours 149 1.73 258 0.25 64.44 149 0.56 83 0.40 33.38 149 45 248 207 248 228 138 248 3.72 1.16 22.46 37.73 53.71 0.00 0.78 72.58 554 52 5,570 7,810 13,320 0 108 18,000 0.75 0.33 0.23 0.13 0.03 0.03 5.17 0.06 415.71 17.23 1,281.12 1,015.31 399.60 0.00 556.50 1,079.99 18,697 .............................. 3,184,246 .................... 851,565.51 * The numbers of respondents and the numbers of total responses in the burden table were updated with 2023 OPTN data and reflect increases in the number of organ transplants and changes in the number of respondents (Transplant Centers, OPOs, and Histocompatibility Labs). ** These two forms will not be used once the OPTN Process Data OMB package is approved and implemented. The OPTN Process Data OMB package is new and will be considered separate from this package. We are including these forms in this collection to avoid any lapse in approval of these forms while the OPTN Process Data package is being approved. *** These are new forms. **** If a form has 0.00 under average number of responses, this is an indicator that there were no submissions in calendar year 2023. HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Amy P. McNulty, Deputy Director, Executive Secretariat. [FR Doc. 2024–25506 Filed 10–31–24; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Child Health and Human Development Council. The meeting will be held as a virtual meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. VerDate Sep<11>2014 16:47 Oct 31, 2024 Jkt 265001 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Child Health and Human Development Council. Date: January 13–14, 2025. Open: January 13, 2025, 12:00 p.m. to 5:00 p.m. Agenda: NICHD Director’s Report and other Council Business. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Closed: January 14, 2025, 9:00 a.m. to 12:15 p.m. Agenda: To review and evaluate grant applications. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebekah S. Rasooly, Ph.D., Director, Division of Extramural Activities, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, 6710B Rockledge Drive, Room: 2316, Bethesda, MD 20817. Any interested person may file written comments with the committee by forwarding the statement to the Contact Persons listed on this notice. The statement should include the name, address, telephone number and when PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/advisory/council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 28, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–25420 Filed 10–31–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should E:\FR\FM\01NON1.SGM 01NON1 Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the National Institute Of Diabetes And Digestive And Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 2024, 09:00 a.m. to November 21, 2024, 08:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on October 25, 2024, FR Doc. No. 2024– 24882, 89 FR 85222. This notice is being amended to change the Panel Name of the meeting from Center for Scientific Review Special Emphasis Panel; PAR Panel: Transformative Research Award for the Include Project to Center for Scientific Review Special Emphasis Panel; RFA– OD–22–009: Transformative Research Award. The meeting is closed to the public. Name of Committee: Board of Scientific Counselors, NIDDK. Date: April 3–4, 2025. Open: April 03, 2025, 10:00 a.m. to 5:00 p.m. Agenda: Introductions and Overview. Address: National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Closed: April 04, 2025, 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual Investigators. Address: National Institutes of Health, Building 10, 10 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael W. Krause, Ph.D., Scientific Director, NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Building 5, Room B104, Bethesda, MD 20892–1818, (301) 402–4633, mwkrause@ helix.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: October 28, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. Dated: October 28, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–25418 Filed 10–31–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, PAR Panel: Transformative Research Award for the Include Project, November 21, VerDate Sep<11>2014 16:47 Oct 31, 2024 Jkt 265001 [FR Doc. 2024–25413 Filed 10–31–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze: Enabling Technologies. Date: December 4, 2024. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 435–0297, email: goltrykl@mail.nih.gov. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 87385 Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze: Product Definition. Date: December 5, 2024. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 435–0297, email: goltrykl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; T32 Diversity Training Grant Applications Review Meeting. Date: December 6, 2024. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Nawazish Ali Naqvi, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208–Y, Bethesda, MD 20892, (301) 827–7911, email: nawazish.naqvi@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Institutional Training T32 Member Conflict SEP. Date: December 9, 2024. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Cynthia D. Anderson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes Health, 6705 Rockledge Drive, Room 207–E, Bethesda, MD 20892, email: cynthia.anderson@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 29, 2024. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–25463 Filed 10–31–24; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\01NON1.SGM 01NON1

Agencies

[Federal Register Volume 89, Number 212 (Friday, November 1, 2024)]
[Notices]
[Pages 87384-87385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25418]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NIDDK.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should

[[Page 87385]]

notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual grant applications conducted by the National Institute Of 
Diabetes And Digestive And Kidney Diseases, including consideration of 
personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.
    Date: April 3-4, 2025.
    Open: April 03, 2025, 10:00 a.m. to 5:00 p.m.
    Agenda: Introductions and Overview.
    Address: National Institutes of Health, Building 10, 10 Center 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Closed: April 04, 2025, 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual Investigators.
    Address: National Institutes of Health, Building 10, 10 Center 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael W. Krause, Ph.D., Scientific Director, 
NIDDK, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institute of Health, Building 5, Room B104, 
Bethesda, MD 20892-1818, (301) 402-4633, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: October 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-25418 Filed 10-31-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.